Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411838 · ClinicalTrials.gov registry record · NA
Calorie Restriction in Multiple Sclerosis Patients
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02411838 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 17 participants.
The verdict
NCT02411838, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The investigators hypothesize that adipokine (soluble molecules produced by the adipose tissue) levels are altered in MS compared to control subjects. Additionally, the investigators hypothesize that calorie restriction (CR) will improve clinical recovery from an MS relapse, ameliorate the adipokine and metabolic-inflammatory profile in MS, and enhance immune-regulatory mechanisms. This is a pilot study to determine the effects of CR in MS patients during an acute MS relapse (Acute CR phase) and for 6 months afterwards (Chronic CR phase). Calorie restriction will be achieved by following a regimen of alternate day fasting. The investigators will evaluate clinical outcomes and blood biomarkers at different time points.
Interventions
- OTHER Calorie restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02411838
The ClinicalTrials.gov registry entry for NCT02411838 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calorie restriction is the first listed.
NCT02411838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02411838 about?
NCT02411838 is a clinical study titled "Calorie Restriction in Multiple Sclerosis Patients". The investigators hypothesize that adipokine (soluble molecules produced by the adipose tissue) levels are altered in MS compared to control subjects. Additionally, the investigators hypothesize that calorie restriction (CR) will improve clinical recovery from an MS relapse, ameliorate the adipokine...
What is the current status of trial NCT02411838?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-02. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02411838?
The interventions under investigation include: Calorie restriction (OTHER).
Who is sponsoring clinical trial NCT02411838?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.